Measurement of Lung Water by Transpulmonary Thermodilution in Lung Transplanted Patients — PICCO-LungT

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Mucoviscidosis Clinical Trial

Official title:
Interest of Repeated Extravascular Lung Water Measurements With the PICCO Device in Lung Transplanted Patients

Status Completed

Clinical Trial Summary

Repeated measurements of lung water by single transpulmonary thermodilution during the first postoperative days following lung transplantation

n/a

Observational Model: Cohort, Time Perspective: Prospective

See also
Status	Clinical Trial	Phase
Terminated	`NCT00391703` - Assessment of Quadriceps Muscle Electrostimulation Used in Patients Suffering From Cystic Fibrosis	N/A
Completed	`NCT04225962` - Intimacy of Women With Cystic Fibrosis
Terminated	`NCT00356629` - Development of a Noninvasive Method of Evaluation of Pulmonary Inflammation in the Condensates of Exhaled Air	N/A
Not yet recruiting	`NCT04625829` - Anthropological Survey on the Use of Essential Oils (EOs) by Cystic Fibrosis Patients: a Quantitative and Qualitative Approach
Completed	`NCT03653377` - Human Papilloma Virus Vaccination in Girls With Cystic Fibrosis (VACCIN-HPV-MUC2)